vs
COMSCORE, INC.（SCOR）与STEM, INC.（STEM）财务数据对比。点击上方公司名可切换其他公司
COMSCORE, INC.的季度营收约是STEM, INC.的2.0倍（$93.5M vs $47.1M），COMSCORE, INC.净利率更高（3.2% vs -33.9%，领先37.1%），COMSCORE, INC.同比增速更快（-1.5% vs -15.6%），过去两年STEM, INC.的营收复合增速更高（36.1% vs 3.8%）
Comscore是总部设于美国的全球媒体测量与分析企业，为企业、广告代理商、品牌营销方及媒体出版方提供专业营销数据与分析服务，在全球媒体行业和营销领域拥有广泛影响力。
该公司是一家公开上市的生物制药企业，总部位于加利福尼亚州纽瓦克，专注研发纯化人类神经干细胞，旨在治疗中枢神经系统疾病与瘫痪，其所研发的神经干细胞可分化为中枢神经系统的神经元、星形胶质细胞与少突胶质细胞这三大主要细胞类型。
SCOR vs STEM — 直观对比
营收规模更大
SCOR
是对方的2.0倍
$47.1M
营收增速更快
SCOR
高出14.0%
-15.6%
净利率更高
SCOR
高出37.1%
-33.9%
两年增速更快
STEM
近两年复合增速
3.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $93.5M | $47.1M |
| 净利润 | $3.0M | $-16.0M |
| 毛利率 | 41.0% | 48.9% |
| 营业利润率 | 7.0% | -17.7% |
| 净利率 | 3.2% | -33.9% |
| 营收同比 | -1.5% | -15.6% |
| 净利润同比 | -3.7% | 68.8% |
| 每股收益（稀释后） | $9.50 | $-4.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SCORSTEM
| Q4 25 | $93.5M | $47.1M | ||
| Q3 25 | $88.9M | $38.2M | ||
| Q2 25 | $89.4M | $38.4M | ||
| Q1 25 | $85.7M | $32.5M | ||
| Q4 24 | $94.9M | $55.8M | ||
| Q3 24 | $88.5M | $29.3M | ||
| Q2 24 | $85.8M | $34.0M | ||
| Q1 24 | $86.8M | $25.5M |
净利润SCORSTEM
| Q4 25 | $3.0M | $-16.0M | ||
| Q3 25 | $453.0K | $-23.8M | ||
| Q2 25 | $-9.5M | $202.5M | ||
| Q1 25 | $-4.0M | $-25.0M | ||
| Q4 24 | $3.1M | $-51.1M | ||
| Q3 24 | $-60.6M | $-148.3M | ||
| Q2 24 | $-1.7M | $-582.3M | ||
| Q1 24 | $-1.1M | $-72.3M |
毛利率SCORSTEM
| Q4 25 | 41.0% | 48.9% | ||
| Q3 25 | 40.6% | 35.5% | ||
| Q2 25 | 40.6% | 33.4% | ||
| Q1 25 | 39.6% | 32.4% | ||
| Q4 24 | 42.4% | -4.4% | ||
| Q3 24 | 41.2% | 21.2% | ||
| Q2 24 | 39.5% | 27.6% | ||
| Q1 24 | 42.3% | -95.0% |
营业利润率SCORSTEM
| Q4 25 | 7.0% | -17.7% | ||
| Q3 25 | 1.9% | -33.6% | ||
| Q2 25 | -1.9% | -34.8% | ||
| Q1 25 | -2.4% | -65.0% | ||
| Q4 24 | 4.1% | -84.4% | ||
| Q3 24 | -67.4% | -493.2% | ||
| Q2 24 | -2.2% | -1705.5% | ||
| Q1 24 | -2.2% | -267.0% |
净利率SCORSTEM
| Q4 25 | 3.2% | -33.9% | ||
| Q3 25 | 0.5% | -62.2% | ||
| Q2 25 | -10.6% | 527.8% | ||
| Q1 25 | -4.7% | -76.9% | ||
| Q4 24 | 3.3% | -91.6% | ||
| Q3 24 | -68.5% | -506.3% | ||
| Q2 24 | -2.0% | -1712.6% | ||
| Q1 24 | -1.2% | -283.9% |
每股收益（稀释后）SCORSTEM
| Q4 25 | $9.50 | $-4.40 | ||
| Q3 25 | $-0.86 | $-2.84 | ||
| Q2 25 | $-2.73 | $-1.79 | ||
| Q1 25 | $-1.66 | $-0.15 | ||
| Q4 24 | $-0.47 | $-15.29 | ||
| Q3 24 | $-12.79 | $-18.24 | ||
| Q2 24 | $-1.19 | $-71.81 | ||
| Q1 24 | $-1.08 | $-0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.6M | $48.9M |
| 总债务越低越好 | $41.5M | — |
| 股东权益账面价值 | $111.4M | $-249.4M |
| 总资产 | $407.7M | $308.9M |
| 负债/权益比越低杠杆越低 | 0.37× | — |
8季度趋势，按日历期对齐
现金及短期投资SCORSTEM
| Q4 25 | $23.6M | $48.9M | ||
| Q3 25 | $26.7M | $43.1M | ||
| Q2 25 | $26.0M | $40.8M | ||
| Q1 25 | $31.0M | $58.6M | ||
| Q4 24 | $29.9M | $56.3M | ||
| Q3 24 | $20.0M | $75.4M | ||
| Q2 24 | $14.7M | $89.6M | ||
| Q1 24 | $18.7M | $112.8M |
总债务SCORSTEM
| Q4 25 | $41.5M | — | ||
| Q3 25 | $41.4M | — | ||
| Q2 25 | $41.3M | — | ||
| Q1 25 | $41.3M | — | ||
| Q4 24 | $41.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益SCORSTEM
| Q4 25 | $111.4M | $-249.4M | ||
| Q3 25 | $-26.3M | $-235.7M | ||
| Q2 25 | $-21.7M | $-214.1M | ||
| Q1 25 | $-13.5M | $-417.5M | ||
| Q4 24 | $-8.3M | $-398.4M | ||
| Q3 24 | $-2.7M | $-344.1M | ||
| Q2 24 | $45.8M | $-203.2M | ||
| Q1 24 | $51.4M | $371.6M |
总资产SCORSTEM
| Q4 25 | $407.7M | $308.9M | ||
| Q3 25 | $406.9M | $362.6M | ||
| Q2 25 | $415.9M | $379.2M | ||
| Q1 25 | $421.5M | $405.1M | ||
| Q4 24 | $430.2M | $437.4M | ||
| Q3 24 | $412.5M | $537.8M | ||
| Q2 24 | $474.1M | $691.5M | ||
| Q1 24 | $477.7M | $1.3B |
负债/权益比SCORSTEM
| Q4 25 | 0.37× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.2M | $8.2M |
| 自由现金流经营现金流 - 资本支出 | $2.9M | — |
| 自由现金流率自由现金流/营收 | 3.1% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | 1.07× | — |
| 过去12个月自由现金流最近4个季度 | $21.8M | — |
8季度趋势，按日历期对齐
经营现金流SCORSTEM
| Q4 25 | $3.2M | $8.2M | ||
| Q3 25 | $9.5M | $11.4M | ||
| Q2 25 | $932.0K | $-21.3M | ||
| Q1 25 | $9.1M | $8.5M | ||
| Q4 24 | $-10.0M | $-14.7M | ||
| Q3 24 | $12.5M | $-9.4M | ||
| Q2 24 | $8.7M | $-11.9M | ||
| Q1 24 | $6.9M | $-621.0K |
自由现金流SCORSTEM
| Q4 25 | $2.9M | — | ||
| Q3 25 | $9.4M | — | ||
| Q2 25 | $787.0K | — | ||
| Q1 25 | $8.7M | — | ||
| Q4 24 | $-10.3M | — | ||
| Q3 24 | $12.4M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $6.6M | — |
自由现金流率SCORSTEM
| Q4 25 | 3.1% | — | ||
| Q3 25 | 10.5% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 10.1% | — | ||
| Q4 24 | -10.8% | — | ||
| Q3 24 | 14.0% | — | ||
| Q2 24 | 10.0% | — | ||
| Q1 24 | 7.6% | — |
资本支出强度SCORSTEM
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.3% | — |
现金转化率SCORSTEM
| Q4 25 | 1.07× | — | ||
| Q3 25 | 20.96× | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | -3.19× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SCOR
| Transferred Over Time | $77.1M | 83% |
| Research Insight Solutions | $14.6M | 16% |
| Related Party | $2.5M | 3% |
STEM
暂无分部数据
